Yi-Fang Tsai Selected Research

Yi-Fang Tsai Research Topics

Disease

22	Neoplasms (Cancer) 06/2022 - 05/2009
22	Breast Neoplasms (Breast Cancer) 06/2022 - 05/2009
9	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
8	Triple Negative Breast Neoplasms 06/2022 - 01/2013
1	Necrosis 01/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2021
1	Pain (Aches) 06/2021
1	Hypoxia (Hypoxemia) 01/2021
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 10/2019
1	Flushing 01/2019
1	Overweight 01/2019
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 08/2014
1	Ductal Carcinoma 01/2014
1	Carcinogenesis 05/2009
1	Cholelithiasis 07/2008
1	Cysts 11/2006
1	Bronchogenic Cyst 11/2006
1	Cholangitis 11/2006

Drug/Important Bio-Agent (IBA)

6	Estrogen ReceptorsIBA 01/2022 - 06/2013
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 06/2013
3	Epidermal Growth Factor (EGF)IBA 06/2022 - 01/2017
3	Phenobarbital (Luminal)FDA Link 01/2022 - 01/2014
3	Hormones (Hormone)IBA 01/2022 - 03/2019
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2017
2	human ERBB2 proteinIBA 01/2022 - 03/2019
2	Biomarkers (Surrogate Marker)IBA 10/2021 - 10/2019
2	Pharmaceutical PreparationsIBA 02/2021 - 06/2013
2	Messenger RNA (mRNA)IBA 01/2021 - 10/2019
2	afimoxifene (hydroxytamoxifen)IBA 10/2019 - 01/2019
2	CholesterolIBA 10/2019 - 01/2019
2	4-hydroxy-N-desmethyltamoxifenIBA 10/2019 - 01/2019
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 10/2019 - 01/2019
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2017 - 01/2017
2	Mitochondrial DNA (mtDNA)IBA 10/2011 - 05/2009
1	talazoparibIBA 06/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2021
1	Interleukin-17 (Interleukin 17)IBA 08/2021
1	taxaneIBA 06/2021
1	Polycomb Repressive Complex 2IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	ChemokinesIBA 01/2020
1	CytokinesIBA 01/2020
1	PlatinumIBA 10/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2019
1	BerberineIBA 01/2019
1	Alanine Transaminase (SGPT)IBA 01/2019
1	Plant ExtractsIBA 08/2017
1	rho GTPase-activating proteinIBA 01/2017
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2017
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 11/2015
1	NeurosteroidsIBA 08/2014
1	Methylphenidate (Ritalin)FDA LinkGeneric 08/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2014
1	VimentinIBA 08/2014
1	myo-inositol-1 (or 4)-monophosphatase (inositol monophosphatase)IBA 08/2014
1	Dehydroepiandrosterone (DHEA)IBA 08/2014
1	Biological ProductsIBA 01/2014
1	Cadherins (E-Cadherin)IBA 06/2013
1	Tamoxifen FDA LinkGeneric 06/2013
1	Trastuzumab (Herceptin)FDA Link 06/2013
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2013
1	timosaponin AIIIIBA 01/2013
1	Oxidoreductases (Dehydrogenase)IBA 05/2009
1	NAD (NADH)IBA 05/2009
1	EnzymesIBA 05/2009
1	quinone (benzoquinone)IBA 05/2009
1	AlbuminsIBA 11/2006
1	MucinsIBA 11/2006
1	BilirubinIBA 11/2006

Therapy/Procedure

11	Therapeutics 01/2022 - 06/2013
4	Precision Medicine 06/2022 - 06/2017
3	Drug Therapy (Chemotherapy) 01/2022 - 10/2019
1	Immunotherapy 10/2021
1	Neoadjuvant Therapy 02/2021
1	Laparoscopic Cholecystectomy 07/2008